Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study

被引：117
作者：
Heiblig, Mael [1 ]
Ferrada, Marcela A. [2 ]
Koster, Matthew T. [3 ]
Barba, Thomas [4 ]
Gerfaud-Valentin, Mathieu [5 ]
Mekinian, Arsene [6 ]
Coelho, Henrique [7 ]
Fossard, Gaelle [1 ]
Barraco, Fiorenza [1 ]
Galicier, Lionel [8 ]
Bienvenu, Boris
Hirsch, Pierre [9 ]
Vial, Guillaume [10 ]
Boutin, Anne Blandine [11 ]
Galland, Joris [12 ]
Le Guenno, Guillaume [13 ]
Bigot, Adrien [14 ]
Warrington, Kenneth J. [3 ]
Kermani, Tanaz A. [15 ]
Grayson, Peter C. [2 ]
Patel, Bhavisha A. [16 ]
Beck, David B. [17 ,18 ]
Jamilloux, Yvan [5 ]
Fenaux, Pierre [19 ,20 ]
Sujobert, Pierre [21 ]
机构：
[1] Hosp Civils Lyon, Serv Hematol Clin, Hop Lyon Sud, Pierre B enite, France
[2] NIA, Musculoskeletal & Skin Dis, NIH, Bethesda, MD 20892 USA
[3] Mayo Clin, Div Rheumatol, Rochester, MN USA
[4] Hosp Civils Lyon, Dept Internal Med, Hop Edouard Herriot, Lyon, France
[5] Hosp Civils Lyon, Croix Rousse Univ Hosp, Lyon Imunopathol Federat LIFE, Internal Med, Lyon, France
[6] Hop St Antoine, Assistance Publ Hop Paris, Dept Internal Med, Paris, France
[7] Ctr Hosp Vila Nova Gaia, Dept Hematol, Porto, Portugal
[8] Hop St Joseph, Dept Internal Med, Marseille, France
[9] Sorbonne Univ, Assistance Publ Hop Paris, Serv Hematol Biol, Hop St Antoine, Paris, France
[10] Ctr Hosp Univ Bordeaux, Dept Internal Med & Clin Immunol, Bordeaux, France
[11] Ctr Hosp Alpes Leman, Dept Hematol, Contamine sur Arve, France
[12] Ctr Hosp Bourg Bresse, Med, Hop Fleyriat, Bourg en Bresse, France
[13] Ctr Hosp Univ Estaing, Serv Med Interne, Clermont Ferrand, France
[14] CHRU Tours, Tours, France
[15] Univ Calif Los Angeles, Los Angeles, CA USA
[16] Natl Heart Lung & Blood Inst, Hematol Branch, NIH, Bethesda, MD USA
[17] Natl Human Genome Res Inst, Natl Inst Hlth, Bethesda, MD USA
[18] NYU, New York, NY USA
[19] Hop St Louis, Assistance Publ Hop Paris, Paris, France
[20] Univ Paris, Paris, France
[21] Hosp Civils Lyon, Lab Hematol, Hop Lyon Sud, Pierre Benite, France
来源：
BLOOD | 2022年 / 140卷 / 08期
关键词：
RHEUMATOID-ARTHRITIS;
D O I：
10.1182/blood.2022016642
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：927 / 931
页数：5
相关论文
共 12 条
  • [1] The Risk of Infections Associated With JAK Inhibitors in Rheumatoid Arthritis A Systematic Review and Network Meta-analysis
    Alves, Carlos
    Penedones, Ana
    Mendes, Diogo
    Marques, Francisco Batel
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2022, 28 (02) : E407 - E414
  • [2] Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease
    Beck, David B.
    Ferrada, Marcela A.
    Sikora, Keith A.
    Ombrello, Amanda K.
    Collins, Jason C.
    Pei, Wuhong
    Balanda, Nicholas
    Ross, Daron L.
    Ospina Cardona, Daniela
    Wu, Zhijie
    Patel, Bhavisha
    Manthiram, Kalpana
    Groarke, Emma M.
    Gutierrez-Rodrigues, Fernanda
    Hoffmann, Patrycja
    Rosenzweig, Sofia
    Nakabo, Shuichiro
    Dillon, Laura W.
    Hourigan, Christopher S.
    Tsai, Wanxia L.
    Gupta, Sarthak
    Carmona-Rivera, Carmelo
    Asmar, Anthony J.
    Xu, Lisha
    Oda, Hirotsugu
    Goodspeed, Wendy
    Barron, Karyl S.
    Nehrebecky, Michele
    Jones, Anne
    Laird, Ryan S.
    Deuitch, Natalie
    Rowczenio, Dorota
    Rominger, Emily
    Wells, Kristina V.
    Lee, Chyi-Chia R.
    Wang, Weixin
    Trick, Megan
    Mullikin, James
    Wigerblad, Gustaf
    Brooks, Stephen
    Dell'Orso, Stefania
    Deng, Zuoming
    Chae, Jae J.
    Dulau-Florea, Alina
    Malicdan, May C. V.
    Novacic, Danica
    Colbert, Robert A.
    Kaplan, Mariana J.
    Gadina, Massimo
    Savic, Sinisa
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (27) : 2628 - 2638
  • [3] Therapeutic options in VEXAS syndrome: insights from a retrospective series
    Bourbon, Estelle
    Heiblig, Mael
    Valentin, Mathieu Gerfaud
    Barba, Thomas
    Durel, Cecile-Audrey
    Lega, Jean Christophe
    Barraco, Fiorenza
    Seve, Pascal
    Jamilloux, Yvan
    Sujobert, Pierre
    [J]. BLOOD, 2021, 137 (26) : 3682 - 3684
  • [4] Autoimmune pathways in mice and humans are blocked by pharmacological stabilization of the TYK2 pseudokinase domain
    Burke, James R.
    Cheng, Lihong
    Gillooly, Kathleen M.
    Strnad, Joann
    Zupa-Fernandez, Adriana
    Catlett, Ian M.
    Zhang, Yifan
    Heimrich, Elizabeth M.
    McIntyre, Kim W.
    Cunningham, Mark D.
    Carman, Julie A.
    Zhou, Xiadi
    Banas, Dana
    Chaudhry, Charu
    Li, Sha
    D'Arienzo, Celia
    Chimalakonda, Anjaneya
    Yang, XiaoXia
    Xie, Jenny H.
    Pang, Jian
    Zhao, Qihong
    Rose, Shawn M.
    Huang, Jinwen
    Moslin, Ryan M.
    Wrobleski, Stephen T.
    Weinstein, David S.
    Salter-Cid, Luisa M.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (502)
  • [5] Azacitidine for patients with Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry
    Comont, Thibault
    Heiblig, Mael
    Riviere, Etienne
    Terriou, Louis
    Rossignol, Julien
    Bouscary, Didier
    Rieu, Virginie
    Le Guenno, Guillaume
    Mathian, Alexis
    Aouba, Achille
    Vinit, Julien
    Dion, Jeremie
    Kosmider, Olivier
    Terrier, Benjamin
    Georgin-Lavialle, Sophie
    Fenaux, Pierre
    Mekinian, Arsene
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (04) : 969 - 974
  • [6] Translating JAKs to Jakinibs
    Gadina, Massimo
    Chisolm, Danielle A.
    Philips, Rachael L.
    McInness, Lain B.
    Changelian, Paul S.
    O'Shea, John J.
    [J]. JOURNAL OF IMMUNOLOGY, 2020, 204 (08) : 2011 - 2020
  • [7] Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients
    Georgin-Lavialle, S.
    Terrier, B.
    Guedon, A. F.
    Heiblig, M.
    Comont, T.
    Lazaro, E.
    Lacombe, V
    Terriou, L.
    Ardois, S.
    Bouaziz, J-D
    Mathian, A.
    Le Guenno, G.
    Aouba, A.
    Outh, R.
    Meyer, A.
    Roux-Sauvat, M.
    Ebbo, M.
    Zhao, L. P.
    Bigot, A.
    Jamilloux, Y.
    Guillotin, V
    Flamarion, E.
    Henneton, P.
    Vial, G.
    Jachiet, V
    Rossignol, J.
    Vinzio, S.
    Weitten, T.
    Vinit, J.
    Deligny, C.
    Humbert, S.
    Samson, M.
    Magy-Bertrand, N.
    Moulinet, T.
    Bourguiba, R.
    Hanslik, T.
    Bachmeyer, C.
    Sebert, M.
    Kostine, M.
    Bienvenu, B.
    Biscay, P.
    Liozon, E.
    Sailler, L.
    Chasset, F.
    Audemard-Verger, A.
    Duroyon, E.
    Sarrabay, G.
    Borlot, F.
    Dieval, C.
    Cluzeau, T.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (03) : 564 - 574
  • [8] Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1
    Obiorah, Ifeyinwa Emmanuela
    Patel, Bhavisha A.
    Groarke, Emma M.
    Wang, Weixin
    Trick, Megan
    Ombrello, Amanda K.
    Ferrada, Marcela A.
    Wu, Zhijie
    Gutierrez-Rodrigues, Fernanda
    Lotter, Jennifer
    Wilson, Lorena
    Hoffmann, Patrycja
    Cardona, Daniela Ospina
    Patel, Nisha
    Dulau-Florea, Alina
    Kastner, Daniel L.
    Grayson, Peter C.
    Beck, David B.
    Young, Neal S.
    Calvo, Katherine R.
    [J]. BLOOD ADVANCES, 2021, 5 (16) : 3203 - 3215
  • [9] Risk of admission to hospital for serious infection after initiating tofacitinib versus biologic DMARDs in patients with rheumatoid arthritis: a multidatabase cohort study
    Pawar, Ajinkya
    Desai, Rishi J.
    Gautam, Nileesa
    Kim, Seoyoung C.
    [J]. LANCET RHEUMATOLOGY, 2020, 2 (02) : E84 - E98
  • [10] Thromboembolism with Janus Kinase (JAK) Inhibitors for Rheumatoid Arthritis: How Real is the Risk?
    Scott, Ian C.
    Hider, Samantha L.
    Scott, David L.
    [J]. DRUG SAFETY, 2018, 41 (07) : 645 - 653
12